MedTrace Logo

Use of Dexamethasone in Pediatric Asthma Exacerbations

NCT02192827 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 318

Last updated 2023-03-30

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the efficacy of a single dose of dexamethasone vs. two doses of dexamethasone in mild and moderate asthma exacerbations pediatric patients.

Conditions

Interventions

DRUG

Dexamethasone Sodium Phosphate Injection

Sponsors & Collaborators

  • University at Buffalo

    lead OTHER

Principal Investigators

  • Meghan E Martin, MD · Johns Hopkins All Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2018-03-31
Completion
2018-03-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02192827 on ClinicalTrials.gov